#Cardiometabolic monitoring kits Market
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
Tumblr was acquired by Yahoo for $1.1B in 2013.
Text
Thailand Point-of-Care Testing Market Growth Drivers, Challenges, and Strategic Insights
Executive Summary Thailand Point-of-Care Testing (POCT) Market :
Data Bridge Market Research analyses that the Thailand point-of-care testing (POCT) market which was USD 139.18 million in 2022, would reach up to USD 251.94 million by 2030, and is expected to undergo a CAGR of 7.70% during the forecast period.
Thailand Point-of-Care Testing (POCT) Market report offers sustainable forward looking growth programs to ensure business success which is imperative for organizations. The report is very helpful for making a correct decision regarding the market and achieving a great success. It classifies the global Thailand Point-of-Care Testing (POCT) Market size with respect to its value & volume by manufacturers, type, application, and region. The research study and research data covered in this market report makes this document a handy resource for managers, analysts, industry experts, and other key people get ready-to-access and self-analyzed study. The Thailand Point-of-Care Testing (POCT) Market report also measures the existing development trends and patterns along with distribution and marketing channels.
The Thailand Point-of-Care Testing (POCT) Market study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. With this report not only an unskilled individual but also a professional can easily extrapolate the entire market within a few seconds. Here, market segmentation is carried out in detail based on various parameters that include applications, verticals, deployment model, end user, and geography. Thailand Point-of-Care Testing (POCT) Market document suggests that the market is supposed to witness growth during the forecast period due to growing demand at the end user level.
Discover the latest trends, growth opportunities, and strategic insights in our comprehensive Thailand Point-of-Care Testing (POCT) Market report. Download Full Report: https://www.databridgemarketresearch.com/reports/thailand-point-of-care-testing-poct-market
Thailand Point-of-Care Testing (POCT) Market Overview
**Segments**
- Based on product type, the Thailand Point-of-Care Testing (POCT) market can be segmented into glucose monitoring kits, infectious disease testing kits, cardiometabolic testing kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol testing kits, and others. The infectious disease testing kits segment is expected to dominate the market due to the rising prevalence of infectious diseases in Thailand and the growing need for rapid diagnostic solutions.
- In terms of application, the market can be divided into clinical diagnostics, homecare, and others. The clinical diagnostics segment is projected to hold a significant share as point-of-care testing helps in delivering faster results and enables immediate decision-making by healthcare providers.
- Based on end-user, the market can be categorized into hospitals, clinics, diagnostic laboratories, homecare settings, and others. The hospital segment is anticipated to lead the market as hospitals are the primary healthcare service providers and have a high patient influx requiring rapid diagnostic solutions.
**Market Players**
- Some of the key players operating in the Thailand Point-of-Care Testing (POCT) market include F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthcare Private Limited, BD, ACON Laboratories, Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, Quidel Corporation, Trinity Biotech, and Sysmex Corporation. These companies are focusing on strategic initiatives such as partnerships, collaborations, product launches, and acquisitions to strengthen their market presence in Thailand.
- Local players such as BTS Solution, Medtrust Marketing Co., Ltd., and Biomedics Medical Supplies Co., Ltd. are also actively participating in the market by offering cost-effective point-of-care testing solutions tailored to the local healthcare needs. The competitive landscape of the market is intensifying with the entry of new players and the introduction of innovative technologies to enhance point-of-care testing efficiency in Thailand.
The Thailand Point-of-Care Testing (POCT) market is witnessing remarkable growth driven by factors such as the increasing prevalence of infectious diseases, rising demand for rapid diagnostic solutions, and the emphasis on delivering faster results for immediate clinical decision-making. The segmentation of the market based on product type reveals a diverse landscape with glucose monitoring kits, infectious disease testing kits, and cardiometabolic testing kits leading the way. Among these segments, infectious disease testing kits are poised to dominate the market due to the pressing need to combat infectious diseases effectively in Thailand.
Moving on to the application segment, clinical diagnostics emerges as a significant driver of market growth as point-of-care testing facilitates quicker diagnosis, leading to timely interventions by healthcare providers. This underscores the crucial role of POCT in enhancing healthcare delivery and patient outcomes in Thailand. Furthermore, the end-user segmentation highlights hospitals as the key players in the POCT market, given their pivotal role as primary healthcare service providers catering to a large patient base in need of rapid and accurate diagnostic solutions.
In terms of market players, global giants such as F. Hoffmann-La Roche Ltd, Abbott, and Siemens Healthcare Private Limited, along with local players like BTS Solution and Medtrust Marketing Co., Ltd., are actively shaping the competitive landscape of the Thailand POCT market. These companies are leveraging strategic initiatives like partnerships, product launches, and acquisitions to strengthen their market presence and cater to the evolving healthcare needs in Thailand. The market is witnessing the entry of new players and the introduction of innovative technologies aimed at enhancing the efficiency and effectiveness of point-of-care testing in the country.
As the Thailand POCT market continues to evolve and expand, there is a growing emphasis on personalized healthcare solutions, technological advancements, and the integration of AI and data analytics to optimize diagnostic processes. The market's future trajectory is likely to be defined by advancements in portable testing devices, increasing adoption of telemedicine, and the integration of POCT into routine healthcare practices. Overall, the Thailand POCT market presents lucrative opportunities for both established players and new entrants to capitalize on the country's growing healthcare needs and the demand for rapid, reliable diagnostic solutions.The Thailand Point-of-Care Testing (POCT) market is experiencing substantial growth fueled by several key factors that are shaping the industry landscape. One significant driver is the increasing prevalence of infectious diseases in Thailand, leading to a rising demand for rapid diagnostic solutions that can aid in the timely and effective management of such conditions. This trend is propelling the dominance of infectious disease testing kits within the market segment, as healthcare providers prioritize swift and accurate diagnosis to combat the spread of diseases efficiently.
Moreover, the emphasis on delivering faster results for immediate clinical decision-making is another crucial factor driving the market's growth. Point-of-care testing plays a vital role in clinical diagnostics by providing healthcare professionals with rapid and reliable test results, enabling them to make timely decisions that positively impact patient care outcomes. This underscores the importance of POCT in enhancing healthcare delivery in Thailand, where quick interventions can significantly improve treatment efficacy and patient well-being.
In terms of end-users, hospitals emerge as the primary drivers of market growth in the Thailand POCT market. As key healthcare service providers with a high patient influx, hospitals rely on rapid diagnostic solutions to streamline their workflow processes and ensure efficient patient care delivery. The demand for POCT solutions in hospital settings underscores the critical role that these facilities play in driving market expansion and adoption of point-of-care testing technologies.
The competitive landscape of the Thailand POCT market is characterized by the presence of both global players and local entities striving to strengthen their market foothold through strategic initiatives such as partnerships, product launches, and acquisitions. While global giants like F. Hoffmann-La Roche Ltd and Abbott bring advanced technologies and extensive expertise to the market, local players like BTS Solution and Medtrust Marketing Co., Ltd. are actively contributing by offering tailored, cost-effective solutions that cater to the specific healthcare needs of the region.
Looking ahead, the future of the Thailand POCT market is poised for further growth driven by the ongoing advancements in portable testing devices, increased adoption of telemedicine, and the integration of AI and data analytics into diagnostic processes. These trends indicate a shift towards personalized healthcare solutions and a more streamlined approach to patient care through the utilization of innovative technologies. Overall, the Thailand POCT market presents a lucrative opportunity for industry players to capitalize on the country's evolving healthcare landscape and the growing demand for rapid, efficient diagnostic solutions.
The Thailand Point-of-Care Testing (POCT) Market is highly fragmented, featuring intense competition among both global and regional players striving for market share. To explore how global trends are shaping the future of the top 10 companies in the keyword market.
Learn More Now: https://www.databridgemarketresearch.com/reports/thailand-point-of-care-testing-poct-market/companies
DBMR Nucleus: Powering Insights, Strategy & Growth
DBMR Nucleus is a dynamic, AI-powered business intelligence platform designed to revolutionize the way organizations access and interpret market data. Developed by Data Bridge Market Research, Nucleus integrates cutting-edge analytics with intuitive dashboards to deliver real-time insights across industries. From tracking market trends and competitive landscapes to uncovering growth opportunities, the platform enables strategic decision-making backed by data-driven evidence. Whether you're a startup or an enterprise, DBMR Nucleus equips you with the tools to stay ahead of the curve and fuel long-term success.
Key Benefits of the Report:
This study presents the analytical depiction of the global Thailand Point-of-Care Testing (POCT) Marketindustry along with the current trends and future estimations to determine the imminent investment pockets.
The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Thailand Point-of-Care Testing (POCT) Market share.
The current market is quantitatively analyzed from to highlight the Global Thailand Point-of-Care Testing (POCT) Market growth scenario.
Porter's five forces analysis illustrates the potency of buyers & suppliers in the market.
The report provides a detailed global Thailand Point-of-Care Testing (POCT) Market analysis based on competitive intensity and how the competition will take shape in coming years
Browse More Reports:
Global Coconut Water Market Global Medical Billing Software Market Global Public Safety Solution Market Global Gourmet Salt Market Middle East and Africa API Intermediates Market Asia-Pacific Loyalty Management Market Global Bone Substitutes Market Global Heat Transfer Film Market Global Aquafeed Premix Market Global Soy Protein Isolate Market Global Vaginitis Therapeutics Market Global Methyl Methacrylate (MMA) Film and Sheet Market North America API intermediates Market Global Remote Patient Monitoring and Care Market Global Minocycline Hydrochloride Market Global In Vivo Preclinical Brain Imaging Devices Market Europe and U.S. Cleaner and Degreaser Market Global Necrotizing Fasciitis Market Global Household Cooking Appliances Market India Non-Stick Cookware Market Global Catheter Stabilization Device/Catheter Securement Devices Market Global Antidepressants Market Global Electronics Access Control Systems Market Global Vapour Recovery Units Market Global Golf Trolley Market Global Trichiasis Treatment Market Global Baricitinib Market Middle East and Africa Microbial Air sampler Market Global Weight Management Diet Market Global Data Center Server Market Global Cell Culture Market Middle East and Africa Metal Injection Molding (MIM) Market Global Patient Engagement Solutions Market Global Rock Salt Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email:- [email protected]
Thailand Point-of-Care Testing (POCT) Market, Thailand Point-of-Care Testing (POCT) Market Trends, Thailand Point-of-Care Testing (POCT) Market Growth, Thailand Point-of-Care Testing (POCT) Market Demand, Thailand Point-of-Care Testing (POCT) Market Size, Thailand Point-of-Care Testing (POCT) Market Scope, Thailand Point-of-Care Testing (POCT) Market Insights, Thailand Point-of-Care Testing (POCT) Market Analysis
0 notes
Text
The globalpoc immunoassay testing market is projected to reach USD 42.6 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 10.2% during the forecast period 2024-2030. The growth of the marketis majorly driven by the increasing number of regulatory approvals for novel immunoassay techniques
0 notes
Text
Rapid Diagnostics Market Size, Share & Forecast: 2028
Rapid Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza), Coagulation), Platform (Microfluidics, Immunoassay), Mode of Purchase (Prescription, OTC), Enduser (Hospital, e-comm, Home Care), and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
Market Overview:
The Rapid Diagnostics market size is projected to reach a CAGR of 11.6% from 2022 to 2028.
Rapid Diagnostics are the medical techniques which are used for the diagnosis and the detection of the disease but are way to perform and are quick. These techniques play major role in the situation wherein the preliminary or the emergency situation similar to the ongoing pandemic. These test kits tend to provide the results in either 20 minutes or the same day.
The technological advancements in the sector along with the surge in the incidents of the infectious disease are some of the factors that have supported long-term expansion for Rapid Diagnostics Market.
COVID-19 had a positive effect on the market, as because the global demand has increased to various folds and also the shortage of lab-based testing facilities the demand for rapid diagnostics was increased.
Request Research Sample Pages: https://www.delvens.com/get-free-sample/rapid-diagnostics-market-trends-forecast-till-2028
Regional Analysis
North America is the most rapidly growing market and offers a huge opportunity for the industry, whose growth is driven by the incidents of lifestyle disorder becoming popular in the region and also the presence of the key players in the region.
Competitive Landscape
Key Players
Roche Diagnostics
Siemens Healthineers
Danaher Corporation
Becton Dickinson and Company
Abbott Laboratories
Quidel Diagnostics
Chembio Diagnostics
EKF Diagnostics
Trinity Biotech
Fluxergy
Recent Developments
In June 2019, FDA gave the approval to Roche diagnostics for VENTANA PD-L1 (SP142) Assay.
Make an Inquiry Before the Purchase: https://www.delvens.com/Inquire-before-buying/rapid-diagnostics-market-trends-forecast-till-2028
Reasons to Acquire
Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
Gain authentic and granular data access for Rapid Diagnostics Market so as to understand the trends and the factors involved behind changing market situations
Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns
Report Scope
Rapid Diagnostics Market is segmented into product, platform, mode of purchase, end users and region.
On the basis of Product
Glucose Monitoring Products
Cardiometabolic Monitoring Products
Infectious Disease Testing Products
Coagulation Monitoring Products
Pregnancy & Fertility Testing Products
Fecal Occult Testing Products
Hematology Testing Products
Tumor/Cancer Marker Testing Products
Urinalysis Testing Products
Drugs-of-abuse Testing Products
Cholesterol Testing Products
Other POC Products
On the basis of Purchase
OTC Testing Products
Prescription-based Testing Products
On the basis of End-Users
Outpatient & Ambulatory Care Facilities
Hospitals & Critical Care Centers
Home Care Settings 5
Other End Users
On the basis of Region
Asia Pacific
North America
Europe
South America
Middle East & Africa
Purchase the Research Report: https://www.delvens.com/checkout/rapid-diagnostics-market-trends-forecast-till-2028
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Browse For More Related Reports:
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
0 notes
Photo
Landscape Of The Global Point Care Diagnostics Market Outlook: Ken Research Buy Now The point-of-care diagnostic test is a medical diagnostic test accompanied outside the laboratory at or near the place where the patient is accepting the care and also defined as bedside testing or near-patient testing.
#Abbott Laboratories Point of Care Diagnostics Market#Cardiometabolic monitoring kits Market#Coagulation monitoring kits Market Value#Drugs of abuse testing kits Sale Market#France Point of Care Diagnostics Market#Global Glucose monitoring kits Market Demand#Global POC Coagulation Testing Market Dynamics#Global Point of Care Diagnostics Market Forecast#Global Point of Care Diagnostics Market Revenue#Global Point of Care Diagnostics Market Scope#Global Urinalysis testing kits Market Revenue#India Point of Care Diagnostics Market#Infectious disease testing kits Market#Japan Cholesterol testing kits Market#Johnson & Johnson Point of Care Diagnostics Market#MEA Point of Care Diagnostics Market Growth#Nova Biomedical Point of Care Diagnostics Market#Online Point of Care Diagnostics Market Sale#Online sale of Point of Care Diagnostics Market#Point of Care Diagnostics Industry Research Report#Point of Care Diagnostics Market Analysis#Point of Care Diagnostics Market Demand#Point of Care Diagnostics Market Distributors#Point of Care Diagnostics Market Drivers#Point of Care Diagnostics Market Future#Point of Care Diagnostics Market in China#Point of Care Diagnostics Market Key Players#Point of Care Diagnostics Market Manufacturers#Point of Care Diagnostics Market Online Players#Point of Care Diagnostics Market opportunities
0 notes
Text
Trends, Share, Size, Growth, Opportunity, and Forecast 2025 of the Point-of-Care Diagnostics Market
The global POC Diagnostics market is divided into product, end-user, method of prescription, and geographical segments. The Point-of-Care Diagnostics Market kit market is divided into several product categories, including glucose monitoring kit, infectious diseases testing kit, pregnancy and fertility testing kit, haematology testing kit, cardiometabolic monitoring kit, urinalysis testing kit, cholesterol test strips, drug of abuse testing kit, and others. The global point-of-care diagnostics market is divided into professional diagnostic facilities, research laboratories, residences, and others based on end-user. The global point-of-care diagnostics market is divided into two segments depending on prescription: prescription-based Point-of-Care Diagnostics Market and over-the-counter (OTC) point-of-care diagnostics. Prescription-based point-of-care diagnostics are the most commonly utilised and prescribed by healthcare practitioners in healthcare facilities.
Read More @ https://cmiinfopiece.blogspot.com/2022/06/global-point-of-care-diagnostics-market.html
0 notes
Text
Point of Care Diagnostics/Testing Market Size Analysis, Research Study 2027
Point of Care Diagnostics Market -Overview:
According to MRFR analysis, the global Point of Care Diagnostics Market Size is expected to register a CAGR of~11.6% from 2021 to 2027and hold a value of ~USD 36,740.3 million by 2027.
The medical equipment utilized to get an immediate result in examining various diseases, diabetes, cancer, heart diseases, are defined as point of care (POC) diagnostics. These devices include glucose monitoring kits, infectious disease testing kits, pregnancy and fertility testing kits, and drug abuse testing kits, to name a few.
The tests can be employed in a variety of circumstances, with each requiring a different course of action depending on the outcome. The drug screening kit can be used for several different purposes. In general, the test is used to determine whether or not a person has consumed any narcotic substance. Sportsmen and women can take the test to ensure that no narcotic substances are present before competing. The advent of portable POC devices supporting government policies is supplementing the POC diagnostics/testing market, with an increasing number of chronic conditions such as diabetes around the globe and a relatively small number of healthcare facilities in developing nations. In addition, market participants are introducing digital and wireless POC solutions to improve diagnosis efficiency and accuracy.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10642 Regional Analysis: The market for point-of-care diagnostics is dominated by North America (which includes the United States and Canada). With the rising incidence and prevalence of lifestyle diseases, North America is gaining traction. More awareness of self-testing and home care goods and a considerable adoption of novel technologies are projected to play a crucial role in driving the point-of-care diagnostics market in North America. Healthcare product providers are merging and acquiring current market participants to extend their product availability across the region. Lacuna Diagnostics (US), a company that provides digital cytology point of care and telehealth services, was bought by Heska Corporation (US).
Owing to the limited availability of healthcare workers, various manufacturing facilities, changing demographics, and increasing consumer healthcare expectations, the Asia-Pacific point of care diagnostics/testing market is expected to be the fastest-growing market sector. Furthermore, comforting government rules, significant funding by industry participants, and innovative technically advanced solutions are all elements boosting the point of care diagnostics/testing market.
Segmentation: The global point of care diagnostics/testing market is categorized into product, end user, mode of purchase, and platform. Based on the product category, the market has been segregated into glucose monitoring, pregnancy & fertility testing, infectious disease testing, drug abuse testing, coagulation monitoring, cardiometabolic monitoring, cancer/tumor marker testing, hematology testing, urinalysis testing, cholesterol, and others. The glucose monitoring segment is expected to hold a considerable share of the market in 2020. Increasing POC urine hCG (Human Chorionic Gonadotropin) tests to diagnose pregnancy is fueling the market growth. Companies such as Abbott (US) are offering total β-hCG for the early detection of pregnancy. In addition, rising POC testing for early tumor detection is strengthening the demand for POC diagnostic products.
Based on end user, the global point of care diagnostics/testing market has been classified as hospitals & clinics, diagnostics centers, homecare/self-testing, and others. Hospitals &clinics held the largest segment share in 2020, owing to easy maneuvering, sample processing, and quick delivery of results. A laboratory information system also manages and stores patient’s test data for further reference, which further drives the market growth. Additionally, the demand for homecare/self-testing is accelerating due to increasing health risks during the pandemic outbreak and rising connectivity between patients and health care providers.
Based on mode of purchase, the global point of care diagnostics/testing market has been classified as over-the-counter (OTC) testing products and prescription-based testing products. The OTC testing products aim to hold a larger market share in the mode of purchase category. OTC products are sold without the prescription for generic disease-diagnosed patients. Theycomply with certain parameters that include the highest standards for efficacy and safety, Good Manufacturing Practice (GMP) manufacturing, stability testing, and labeling under 21 CFR 201.66. According to the FDA, over 300,000 marketed OTC drug products are categorized into 80 therapeutic classes. The largevariety and availability of the products are driving the point of care diagnostics/testing market.
Based on the platform, the global point of care diagnostics/testing market has been classified as immunoassays, molecular diagnostics, dipstick, and others. Immunoassays is estimated to hold the largest segment share in 2020, owing to the increasing demand forthe products for testing particular antibodies or a specific antigen in blood or other body fluids. The immunoassays-based POC test is carried out in countries with low resources and facilities. Among the immunoassays, lateral flow immunoassays are highly used for quick diagnosis as they are sensitive to specific antigens and offer quick & accurate results.
Key Players:
Some of the key players in the global point of care diagnostics/testing market are Abbott Laboratories (US), Siemens Healthineers GmbH (Germany), Chembio Diagnostics, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson Services, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), PTS Diagnostics (US), Nova Biomedical (US), Quidel Corporation (US), Sekisui Diagnostics (US), Trinity Biotech (Ireland), AccuBioTech Co., Ltd.(China), Instrumentation Laboratory Company (Werfen) (US), and EKF Diagnostics Holdings plc (UK) among others.
Browse Detailed TOC with COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/point-of-care-diagnostics-testing-market-10642
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
0 notes
Link
0 notes
Text
Europe Point-Of-Care-Testing Market Size, Share, Trends, Growth Opportunities and Competitive Outlook
Executive Summary Europe Point-Of-Care-Testing (POCT) Market :
Europe Point-Of-Care Testing (POCT) Market size was valued at USD 21.63 billion 2024 and is projected to reach USD 10.65 billion by 2032, with a CAGR of 9.3% during the forecast period of 2025 to 2032.
Europe Point-Of-Care-Testing (POCT) Market business market research report help you stay up-to-date about the whole market and also give holistic view of the market. Market research analysis provides the insights which help to have a more precise understanding of the market landscape, issues that may impinge on the industry in the future, and how to position specific brands in the best way. With this report one can focus on the data and realities of the industry which keeps them on the right path. The insights covered in this Europe Point-Of-Care-Testing (POCT) Market report will guide for an actionable ideas, better decision-making and better business strategies.
With Europe Point-Of-Care-Testing (POCT) Market international market research report it becomes easy to do estimations about the investment in an emerging market, expansion of market share or success of a new product. Market research analysis makes the professional reputation better in the field, builds more credibility in the work and helps other participants to have more assurance and trust in your conclusions. This market report guides all sizes of businesses by providing informed decisions on the different aspects of business. Europe Point-Of-Care-Testing (POCT) Market report has been formulated by understanding the significance of sound facts and figures required for any research.
Discover the latest trends, growth opportunities, and strategic insights in our comprehensive Europe Point-Of-Care-Testing (POCT) Market report. Download Full Report: https://www.databridgemarketresearch.com/reports/europe-poct-market
Europe Point-Of-Care-Testing (POCT) Market Overview
**Segments**
- Based on product, the Europe Point-Of-Care-Testing (POCT) market can be segmented into glucose monitoring kits, infectious disease testing kits, cardiometabolic monitoring kits, coagulation monitoring kits, pregnancy and fertility testing kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drug-of-abuse testing kits, fecal occult testing kits, and others. - On the basis of mode of prescription, the market can be categorized into prescription-based testing and OTC testing. - Depending on platform, the POCT market in Europe consists of lateral flow assays, dipsticks, microfluidics, molecular diagnostics, immunoassays, and others. - By end-user, the market is classified into hospitals, home care settings, clinics, diagnostic laboratories, and others.
**Market Players**
- Some of the key players operating in the Europe POCT market include Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, BD, bioMérieux SA, Johnson & Johnson Services, Inc., PTS Diagnostics, Werfen, QIAGEN, Sekisui Diagnostics, and Trividia Health, Inc.
The Europe Point-Of-Care-Testing (POCT) market is a dynamic and rapidly evolving sector that offers a wide range of opportunities for growth and innovation. One of the key trends shaping the market is the increasing demand for convenient and rapid diagnostic solutions, particularly in settings such as hospitals, clinics, and home care environments. The shift towards personalized medicine and the need for quicker and more accurate test results are driving the adoption of POCT devices across Europe.
One of the significant drivers of the Europe POCT market is the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and infectious diseases. POCT devices play a crucial role in the early detection and monitoring of these conditions, leading to better patient outcomes and reduced healthcare costs. The focus on preventive healthcare and the emphasis on early diagnosis are also fueling the demand for POCT solutions in the region.
The competitive landscape of the Europe POCT market is characterized by the presence of a diverse range of players, including multinational corporations, medium-sized enterprises, and start-ups. Companies such as Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, and BD are among the key players driving innovation and technological advancements in the market. These companies are investing in research and development activities to launch new products and enhance their existing portfolio to cater to the evolving needs of healthcare providers and patients.
Regulatory factors also play a significant role in shaping the Europe POCT market. Stringent regulations governing the approval and commercialization of POCT devices are influencing the market dynamics and competition among players. Companies that can navigate the regulatory landscape effectively and ensure compliance with standards and guidelines are better positioned to succeed in the market.
The increasing adoption of digital health solutions and telemedicine platforms is creating new opportunities for POCT market players to expand their reach and offer integrated healthcare solutions. The convergence of healthcare technology, data analytics, and artificial intelligence is paving the way for innovative POCT devices that can deliver real-time insights and personalized recommendations to users.
Overall, the Europe POCT market holds immense potential for growth and innovation, driven by factors such as the increasing prevalence of chronic diseases, the emphasis on preventive healthcare, technological advancements, and regulatory developments. Market players that can differentiate their products, forge strategic partnerships, and stay ahead of the curve in terms of innovation are likely to experience sustained growth and success in the dynamic and competitive landscape of the Europe POCT market.The Europe Point-Of-Care-Testing (POCT) market is experiencing significant growth and evolution driven by various factors such as the demand for convenient and rapid diagnostic solutions, increasing prevalence of chronic diseases, and the shift towards personalized medicine. The market segmentation based on product diversity reflects the wide array of applications for POCT devices, ranging from glucose monitoring and infectious disease testing to pregnancy and fertility testing. This variety indicates the versatility and adaptability of POCT solutions to cater to different healthcare needs and diagnostic requirements.
The mode of prescription segmentation further showcases the different channels through which POCT devices are accessed, whether through prescription-based testing or over-the-counter availability. This distinction highlights the accessibility and flexibility of POCT devices, catering to both healthcare professionals and consumers seeking quick and reliable diagnostic results. The market players in the Europe POCT market consist of industry giants such as Abbott, Roche, and Siemens, along with other key players driving innovation and technological advancements in the sector.
The competitive landscape within the Europe POCT market underscores the importance of research and development activities in driving product innovation and differentiation. Companies investing in cutting-edge technologies and regulatory compliance are better positioned to capitalize on the growing demand for POCT solutions in the region. The integration of digital health solutions and telemedicine platforms further amplifies the opportunities for market expansion and the delivery of integrated healthcare services using POCT devices.
Regulatory factors play a crucial role in shaping the market dynamics and influencing competition among players. Compliance with stringent regulations and standards is essential for market players to navigate the regulatory landscape effectively and ensure the commercial success of their POCT devices. The convergence of healthcare technology, data analytics, and artificial intelligence presents new avenues for developing innovative POCT devices that provide real-time insights and personalized recommendations to users.
In conclusion, the Europe POCT market offers immense potential for growth and innovation, driven by the increasing prevalence of chronic diseases, technological advancements, regulatory developments, and the emphasis on preventive healthcare. Market players that focus on product differentiation, strategic partnerships, and continuous innovation are likely to thrive in the competitive landscape of the Europe POCT market. The evolving market trends and consumer demands present opportunities for companies to enhance their product offerings and create value-added solutions that address the evolving healthcare needs across Europe.
The Europe Point-Of-Care-Testing (POCT) Market is highly fragmented, featuring intense competition among both global and regional players striving for market share. To explore how global trends are shaping the future of the top 10 companies in the keyword market.
Learn More Now: https://www.databridgemarketresearch.com/reports/europe-poct-market/companies
DBMR Nucleus: Powering Insights, Strategy & Growth
DBMR Nucleus is a dynamic, AI-powered business intelligence platform designed to revolutionize the way organizations access and interpret market data. Developed by Data Bridge Market Research, Nucleus integrates cutting-edge analytics with intuitive dashboards to deliver real-time insights across industries. From tracking market trends and competitive landscapes to uncovering growth opportunities, the platform enables strategic decision-making backed by data-driven evidence. Whether you're a startup or an enterprise, DBMR Nucleus equips you with the tools to stay ahead of the curve and fuel long-term success.
Key Pointers Covered in the Europe Point-Of-Care-Testing (POCT) Market Industry Trends and Forecast
Europe Point-Of-Care-Testing (POCT) Market Size
Europe Point-Of-Care-Testing (POCT) Market New Sales Volumes
Europe Point-Of-Care-Testing (POCT) Market Replacement Sales Volumes
Europe Point-Of-Care-Testing (POCT) Market By Brands
Europe Point-Of-Care-Testing (POCT) Market Procedure Volumes
Europe Point-Of-Care-Testing (POCT) Market Product Price Analysis
Europe Point-Of-Care-Testing (POCT) Market Regulatory Framework and Changes
Europe Point-Of-Care-Testing (POCT) Market Shares in Different Regions
Recent Developments for Market Competitors
Europe Point-Of-Care-Testing (POCT) Market Upcoming Applications
Europe Point-Of-Care-Testing (POCT) Market Innovators Study
Browse More Reports:
Global Digital Holographic Display Market Global Animal Feed Acidifier Market Global Polyvinyl Butyral Market Global Lyme Disease Drug Market Asia-Pacific Reverse Logistics Market Middle East and Africa Remote Patient Monitoring and Care Market Global Hepatitis C Diagnosis and Treatment Market Global Sleep Tech Devices Market Global Paperboard Beverage Packaging Market Global Single-use Bioprocessing Systems Market Global Nanobots Market Global Oxidative Stress Assay Instruments Market Global Plastic Baby Food Packaging Market North America Conversational AI Market Global In-Memory Computing Market North America Reverse Logistics Market Global Imaging Infrared Light Emitting Diode (LED) Market Global Inherited Retinal Diseases Market Global Broadband Internet Access Services Market Global Plant Based Food Packaging Market Global Rare Earth Elements Market Global Automotive Natural Gas Vehicle Market North America Automotive DC-DC Converters Market Europe Non-stick Cookware Market Global Connected Care Market Global Triple A Syndrome Treatment Market North America Fluoroscopy - C Arms Market Global Video Conferencing Systems Market Global Automotive DC-DC Converters Market Global High Performance Lubricant Market North America Clinical Chemistry Analyser Market Global Performance Chemicals Market Global Vehicle Diagnostics Market Global Meatless Flavor Additives Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email:- [email protected]
0 notes
Text
US Anticoagulation Therapy Market worth USD 27.83 Billion : Indicates Impressive Growth Rate In Pharmacy-based And Medical device Industry
The market is segmented into products (anticoagulation drugs and PT/INR testing devices) and anticoagulation clinics. The growth in the anticoagulation drugs market is primarily driven by the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs). On the other hand, the high cost of NOACs and requirement of significant investments in the development of anticoagulation drugs are the major factors restraining the growth of this market.
According to a new market research report “US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Service Type (Testing & Consulting), Type of Clinic (Hospital Associated, Independent & Pharmacy-based) – Forecast to 2022“, published by MarketsandMarkets™, the market has witnessed a healthy growth rate during the last decade and is expected to grow at a CAGR of 8.5% between 2017 and 2022 to reach USD 27.83 Billion by 2022.
Browse in-depth TOC on “US Anticoagulation Therapy Market“
29 Tables 25 Figures 86 Pages
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=114158575
Factors such as the rising incidence of venous thromboembolism, atrial fibrillation, and stroke; long-term administration and high volume of recurring sales of anticoagulation drugs; and increasing demand for novel oral anticoagulants (NOACs) is driving the growth of this market.
The NOACs segment accounted for the largest share of the US Anticoagulation Therapy Market for drugs in 2016
The US anticoagulation drugs market is categorized into NOACs, warfarin (VKA), and other drugs. In 2016, the NOACs segment accounted for the largest share of the market. Due to the better safety and efficacy of NOACs as compared to traditional therapies, the adoption of NOACs is higher as compared to traditional drugs. In addition, key market players such as Portola Pharmaceuticals (received the FDA approval for its NOAC Betrixaban in July 2017) are focusing on the development of NOACs in order to capitalize on the growth opportunities presented by this shift in market dynamics. Consequently, many other companies are also expected to focus on developing more safe and efficient NOACs in the coming years; this will ensure the continued growth of this segment.
The in-office testing devices accounted for the largest share of the US Anticoagulation Therapy Market for PT/INR testing devices in 2016
The global US Anticoagulation Therapy Market for PT/INR testing devices is segmented into in-office testing devices and home testing devices. In 2016, the in-office testing devices segment dominated the US Anticoagulation Therapy Market for PT/INR testing devices. The large share of this segment is mainly attributed to the large number of patients opting for in-office testing services. However, the home testing devices segment is expected to grow at the highest CAGR due to its advantages such as convenience, time & cost savings, and quick result generation. Additionally, the cost of test devices and the tests themselves are often reimbursable.
By type of service, the testing services held the largest market share of the anticoagulation therapy market for clinics in 2016
On the basis of types of services provided, the US Anticoagulation Therapy Market for clinics is categorized into testing services and consulting services. In 2016, the testing services segment accounted for the largest share of the US Anticoagulation Therapy Market for clinics. The recurring need for PT/INR monitoring is the key factor driving the growth of this market. However, the shift of patients toward novel anticoagulant agents and high adoption of home testing devices are expected to restrain the growth of this market to a certain extent
By type of clinics, hospital associated clinics held the largest market share of the anticoagulation therapy market for clinics in 2016
On the basis of type of clinics, the US Anticoagulation Therapy Market for clinics is categorized into hospital associated clinics, independent clinics, and pharmacy-based clinics. In 2016, the hospital associated clinics segment accounted for the largest share of the US Anticoagulation Therapy Market for clinics.
Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=114158575
C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in the US Anticoagulation Therapy Market for drugs while Roche (Switzerland), Abbott (US), Siemens (Germany), Alere (US), and CoaguSense (US) are the major market players in the US Anticoagulation Therapy Market for PT/INR home testing devices.
Browse Related Reports
Coagulation/Hemostasis Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) – Forecast to 2021
http://www.marketsandmarkets.com/Market-Reports/hemostasis-coagulation-analyzer-market-197226392.html
Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based – Global Forecast to 2021
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “RT” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Rohan MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: [email protected]
0 notes
Text
Europe POCT Device Market to Witness CAGR of 8.6% in the Forecast Period of 2020 to 2027|Key Players Abbott Laboratories, Inc., Alere Inc., roche Diagnostics Limited, Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc.
POCT device market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 6.3 Billion in 2019 growing at a CAGR of 8.8% in the above-mentioned forecast period. The rise of infectious diseases across Europe requires early detection and diagnosis of infectious diseases in the region. Point-of-care testing (POCT) is an important part of the clinical diagnosis market and is rapidly evolving into a preferred test mode as infection, diagnosis leads to lower antibiotic intake, lower laboratory tests for patients, and lower treatment costs. This is not only cost effective for patients but also for hospitals.
The results of diagnostic test take few hours to days that totally depend on the type of disease. Rapid diagnosis is important for survivors. The new regulations, reimbursement laws and technological advancements all focus on making the test accurate, operationally efficient, portable and easy to use. Increasing the scope of POCT equipment, advancements in technology, increased incidence of chronic diseases, increased demand for self-test point care test equipment, decentralized laboratory testing and microscopic laboratory are some of the key factors driving the market. Many market players are constantly trying and updating upcoming products with more up-to-date innovations in portable devices with lower sample volume or less blood to get more success in in-vitro diagnosis related company, which is creating opportunities for the market players. The growing cost of POCT equipment is one of the factors that are hindering the growth of this market.
Europe POCT Device Market, By Product Type (Blood Glucose Testing Kits, Cardio Metabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy and Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing kits, and Others), Prescription (Prescription Based Testing and Over-The-Counter (OTC) Testing), Distribution Channel (Direct Tenders and Retail), End users (Hospital, Clinics, Ambulatory Care, Home Healthcare, and Research Laboratory), Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast to 2027 This Europe POCT device market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research Europe POCT device market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Get More Info Sample Request on Europe POCT Device Market,@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-poct-device-market
Europe POCT Device Market Scope and Market Size:
Europe POCT device market is segmented on the basis of product type, prescription mode, distribution channel, end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insight s to help them in making strategic decisions for identification of core market applications.
Based on product type, the Europe POCT device market is segmented into blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others. Cardiometabolic monitoring kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Also, infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections and respiratory infections testing kit. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.
On the basis of prescription mode, the Europe POCT device market is segmented into prescription based testing and over-the-counter (OTC) testing. On the basis of distribution channel, the Europe POCT device market is segmented into direct tenders and retail. On the basis of end users, the Europe POCT device market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Hospital segment is further categorized into emergency department critical-care unit, general ward, and others. Others are further segmented into intensive care unit, neo-natal.
Key Market Competitors:
The major players covered in the Europe POCT device market report Abbott Laboratories, Inc., Alere Inc., roche Diagnostics Limited, Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
MAJOR TOC OF THE REPORT:
Chapter One: Europe POCT Device Market
Chapter Two: Manufacturers Profiles
Chapter Three: Europe POCT Device Market Competition, by Players
Chapter Four: Europe POCT Device Market Size by Regions
Chapter Five: Europe POCT Device Market Revenue by Countries
Chapter Six: Europe POCT Device Market Revenue by Type
Chapter Seven: Europe POCT Device Market Revenue by Application
Chapter Eight: Europe POCT Device Market Revenue by Industries
Chapter Nine: Europe POCT Device Market Revenue by Deployment Model
Chapter Ten: Europe POCT Device Market Revenue by End User
Get Table of Content on Request @ https://www.databridgemarketresearch.com/toc/?dbmr=europe-poct-device-market
Reasons for buying this Europe POCT Device Market:
Laser Capture Europe POCT Device Market aids in understanding the crucial product segments and their perspective.
Initial graphics and exemplified that a SWOT evaluation of large sections supplied from the Laser Capture Europe POCT Device Market.
Even the Laser Capture Europe POCT Device Market economy provides pin line evaluation of changing competition dynamics and retains you facing opponents.
This report provides a more rapid standpoint on various driving facets or controlling Medical Robotic System promote advantage.
This worldwide Locomotive report provides a pinpoint test for shifting dynamics that are competitive.
The key questions answered in this report:
What will be the Market Size and Growth Rate in the forecast year?
What is the Key Factors driving Laser Europe POCT Device Market?
What are the Risks and Challenges in front of the market?
Who are the Key Vendors in Europe POCT Device Market?
What are the Trending Factors influencing the market shares?
What is the Key Outcomes of Porter’s five forces model
Access Full Report https://www.databridgemarketresearch.com/reports/europe-poct-device-market
Browse Related Report:
Vascular Closure Device Market
Refurbished Medical Device Market
Surgical Staplers Device Market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
0 notes
Text
Point-of-care Testing Market Growing by Increasing Market Share with Leading Players| Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics.
Point-of-care Testing (POCT) Market driving the growth of this market include the rising prevalence of modern lifestyle, increase in chronic and infectious diseases, advancement in technology, scope for unmet medical needs and emerging POCT device. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1c, homocystein. On the other hand, rising costs of POCT device and low reimbursement scenario are regulatory hurdles that may hinder the growth of the market.
APAC POCT Device Market is expected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=apac-point-care-testing-poct-market
Competitive Analysis: APAC Point-of-Care Testing (POCT)
Hoffmann La Roche Diagnostics Limited is dominating the APAC Point-of-Care Testing Market major players followed by Abbott, Alere Inc., Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc., Werfenlife and others.
Key Pointers Covered in the APAC Point-of-Care Testing Market Trends and Forecast to 2026
APAC Point-of-Care Testing Market New Sales Volumes
APAC Point-of-Care Testing Market Replacement Sales Volumes
APAC Point-of-Care Testing Market Installed Base
APAC Point-of-Care Testing Market By Brands
APAC Point-of-Care Testing Market Size
APAC Point-of-Care Testing Market Procedure Volumes
APAC Point-of-Care Testing Market Product Price Analysis
APAC Point-of-Care Testing Market Healthcare Outcomes
APAC Point-of-Care Testing Market Cost of Care Analysis
APAC Point-of-Care Testing Market Regulatory Framework and Changes
APAC Point-of-Care Testing Market Prices and Reimbursement Analysis
APAC Point-of-Care Testing Market Shares in Different Regions
Recent Developments for APAC Point-of-Care Testing Market Competitors
APAC Point-of-Care Testing Market Upcoming Applications
APAC Point-of-Care Testing Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=apac-point-care-testing-poct-market
Market Segmentation: APAC Point-of-care Testing (POCT) Market
The APAC Point-of-care Testing (POCT) Market is segmented on the basis of product, prescription mode, distribution channel, end user and geography.
On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Based on prescription mode, the APAC Point-of-care Testing (POCT) Market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the market is segmented into direct tenders and retail.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.
Asia-Pacific Point-of-Care Testing (POCT) Market Scope and Market Size
Point-of-care testing (POCT) market is segmented on the basis of product, prescription mode, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on product, the point-of-care testing (POCT) market is segmented into blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy & fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits and others.
Based on prescription mode, the point-of-care testing (POCT) market is segmented into prescription and over the counter.
On the basis of distribution channel, the point-of-care testing (POCT) market is segmented into direct tenders and retail.
Point-of-care testing (POCT) market has also been segmented based on the end user into hospital, clinics, ambulatory care, home healthcare and research laboratory.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=apac-point-care-testing-poct-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Laboratory Information System (LIS) Market
Arthroscopy Devices Market
#Point-of-care Testing Market#Point-of-care Testing Market share#Point-of-care Testing Market size#Point-of-care Testing Market trends#Point-of-care Testing Market news
0 notes
Text
Point-of-care Testing Market Size, Industry Growth with key Business Influencing Factors| Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics.
Point-of-care Testing (POCT) Market driving the growth of this market include the rising prevalence of modern lifestyle, increase in chronic and infectious diseases, advancement in technology, scope for unmet medical needs and emerging POCT device. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1c, homocystein. On the other hand, rising costs of POCT device and low reimbursement scenario are regulatory hurdles that may hinder the growth of the market.
APAC POCT Device Market is expected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=apac-point-care-testing-poct-market
Competitive Analysis: APAC Point-of-Care Testing (POCT)
Hoffmann La Roche Diagnostics Limited is dominating the APAC Point-of-Care Testing Market major players followed by Abbott, Alere Inc., Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc., Werfenlife and others.
Key Pointers Covered in the APAC Point-of-Care Testing Market Trends and Forecast to 2026
APAC Point-of-Care Testing Market New Sales Volumes
APAC Point-of-Care Testing Market Replacement Sales Volumes
APAC Point-of-Care Testing Market Installed Base
APAC Point-of-Care Testing Market By Brands
APAC Point-of-Care Testing Market Size
APAC Point-of-Care Testing Market Procedure Volumes
APAC Point-of-Care Testing Market Product Price Analysis
APAC Point-of-Care Testing Market Healthcare Outcomes
APAC Point-of-Care Testing Market Cost of Care Analysis
APAC Point-of-Care Testing Market Regulatory Framework and Changes
APAC Point-of-Care Testing Market Prices and Reimbursement Analysis
APAC Point-of-Care Testing Market Shares in Different Regions
Recent Developments for APAC Point-of-Care Testing Market Competitors
APAC Point-of-Care Testing Market Upcoming Applications
APAC Point-of-Care Testing Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=apac-point-care-testing-poct-market
Market Segmentation: APAC Point-of-care Testing (POCT) Market
The APAC Point-of-care Testing (POCT) Market is segmented on the basis of product, prescription mode, distribution channel, end user and geography.
On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Based on prescription mode, the APAC Point-of-care Testing (POCT) Market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the market is segmented into direct tenders and retail.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.
Asia-Pacific Point-of-Care Testing (POCT) Market Scope and Market Size
Point-of-care testing (POCT) market is segmented on the basis of product, prescription mode, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on product, the point-of-care testing (POCT) market is segmented into blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy & fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits and others.
Based on prescription mode, the point-of-care testing (POCT) market is segmented into prescription and over the counter.
On the basis of distribution channel, the point-of-care testing (POCT) market is segmented into direct tenders and retail.
Point-of-care testing (POCT) market has also been segmented based on the end user into hospital, clinics, ambulatory care, home healthcare and research laboratory.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=apac-point-care-testing-poct-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Laboratory Information System (LIS) Market
Arthroscopy Devices Marke
#Point-of-care Testing Market#Point-of-care Testing Market share#Point-of-care Testing Market size#Point-of-care Testing Market trends#Point-of-care Testing Market news#Point-of-care Testing Market growth#Point-of-care Testing Market forecast
0 notes
Text
Point-of-care Testing (POCT) Market Strategic Insights and key Business Influencing Factors | Major Players – Abbott, Alere Inc., Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics.
Point-of-care Testing (POCT) Market driving the growth of this market include the rising prevalence of modern lifestyle, increase in chronic and infectious diseases, advancement in technology, scope for unmet medical needs and emerging POCT device. These factors increase the demand for devices such as blood glucose meter, CRP, HBA1c, homocystein. On the other hand, rising costs of POCT device and low reimbursement scenario are regulatory hurdles that may hinder the growth of the market.
APAC POCT Device Market is expected to reach USD 4.66 billion by 2024 from USD 2.31 billion in 2016, at a CAGR of 9.2% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get Sample Report at :
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=apac-point-care-testing-poct-market
Register Here: https://www.databridgemarketresearch.com/digital-conference/cell-and-gene-therapy
Competitive Analysis: APAC Point-of-Care Testing (POCT)
Hoffmann La Roche Diagnostics Limited is dominating the APAC Point-of-Care Testing Market major players followed by Abbott, Alere Inc., Siemens AG, Becton, Dickinson and Company, Johnson & Johnson Services Inc., PTS Diagnostics, Instrumentation Laboratory, Nova Biomedical, Beckman Coulter, Inc., Werfenlife and others.
Key Pointers Covered in the APAC Point-of-Care Testing Market Trends and Forecast to 2026
APAC Point-of-Care Testing Market New Sales Volumes
APAC Point-of-Care Testing Market Replacement Sales Volumes
APAC Point-of-Care Testing Market Installed Base
APAC Point-of-Care Testing Market By Brands
APAC Point-of-Care Testing Market Size
APAC Point-of-Care Testing Market Procedure Volumes
APAC Point-of-Care Testing Market Product Price Analysis
APAC Point-of-Care Testing Market Healthcare Outcomes
APAC Point-of-Care Testing Market Cost of Care Analysis
APAC Point-of-Care Testing Market Regulatory Framework and Changes
APAC Point-of-Care Testing Market Prices and Reimbursement Analysis
APAC Point-of-Care Testing Market Shares in Different Regions
Recent Developments for APAC Point-of-Care Testing Market Competitors
APAC Point-of-Care Testing Market Upcoming Applications
APAC Point-of-Care Testing Market Innovators Study
Get Detailed TOC:
https://www.databridgemarketresearch.com/toc/?dbmr=apac-point-care-testing-poct-market
Market Segmentation: APAC Point-of-care Testing (POCT) Market
The APAC Point-of-care Testing (POCT) Market is segmented on the basis of product, prescription mode, distribution channel, end user and geography.
On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others.
Based on prescription mode, the APAC Point-of-care Testing (POCT) Market is segmented into prescription based testing and over-the-counter (OTC) testing.
On the basis of distribution channel, the market is segmented into direct tenders and retail.
On the basis of end users, the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.
Asia-Pacific Point-of-Care Testing (POCT) Market Scope and Market Size
Point-of-care testing (POCT) market is segmented on the basis of product, prescription mode, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on product, the point-of-care testing (POCT) market is segmented into blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy & fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits and others.
Based on prescription mode, the point-of-care testing (POCT) market is segmented into prescription and over the counter.
On the basis of distribution channel, the point-of-care testing (POCT) market is segmented into direct tenders and retail.
Point-of-care testing (POCT) market has also been segmented based on the end user into hospital, clinics, ambulatory care, home healthcare and research laboratory.
Reasons to Purchase this Report:
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Speak to Author :
https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=apac-point-care-testing-poct-market
Key insights in the report:
Complete and distinct analysis of the market drivers and restraints
Key Market players involved in this industry
Detailed analysis of the Market Segmentation
Competitive analysis of the key players involved
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Browse Related Report Here:
Laboratory Information System (LIS) Market
Arthroscopy Devices Market
#Point-of-care Testing (POCT) Market#Point-of-care Testing (POCT) Market share#Point-of-care Testing (POCT) Market size#Point-of-care Testing (POCT) Market trends#Point-of-care Testing (POCT) Market news#Point-of-care Testing (POCT) Market report#Point-of-care Testing (POCT) Market growth#Point-of-care Testing (POCT) Market forecast
0 notes
Text
Point of Care (POC) Diagnostics/Testing Market Research (2020-2025) Report by Size, Share, Revenue, Business Growth, Demand and Applications
Point of Care (POC) Diagnostics/Testing Market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. Point-of-care (POC) diagnostics is referred to as medical testing at or near the site of patient care. These tests are developing in analytical scope, clinical application, and could be easily performed at the bedside. The test mainly involves blood and urine testing. The results of the test are obtained in a very short period.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/point-of-care-poc-diagnostics-testing-market/request-sample
The key driving factors responsible for the growth of Point of Care (POC) Diagnostics/Testing market :
The factors that are playing a major role in the growth of point of care (POC) diagnostics market are the occurrence of chronic diseases, rising inclination toward home healthcare, private investment and project funding towards the development of new products, government initiatives to increase the adoption of POC devices, and efficient workflow process. However, disinclination among patients to change current treatment practices is a factor that is restraining overall market growth.
Point of care (POC) testing market is segmented based on product type, prescription mode, end user, and region. Tumor/cancer markers, fecal occult testing kits, glucose monitoring kits, urinalysis testing kits, drugs of abuse testing kits, cholesterol test strips, hematology testing kits, cardiometabolic monitoring kits, pregnancy and fertility testing kits, infectious diseases testing kits, coagulation monitoring kits, and other product types could be explored in point of care diagnostics market in the forecast period.
Cardiometabolic monitoring kits comprise cardiac markers, blood gas/electrolytes testing kits, hba1c testing kits, lipids testing. Pregnancy and fertility testing kits sector comprise pregnancy-testing kits, fertility-testing kits. Also, infectious diseases testing kits sector comprise influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases (STDs) testing kits, tropical diseases testing kits, healthcare-associated infections (HAIs), respiratory infections testing kits, and others. Coagulation monitoring kits sector comprise prothrombin time (PT/INR) testing kits and activated clotting time (ACT/APTT) testing kits.
Based on the prescription mode, over-the-counter (OTC) testing kits and prescription-based testing kits could classify point of care (POC) diagnostics in the forecast period. Prescription-based testing kits segment accounted for the substantial market share of the point of care testing and is estimated to remain dominant over the forecast period. The reason being, rising chronic diseases and lack of awareness of the point of care (POC) testing.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/point-of-care-poc-diagnostics-testing-market
0 notes
Text
North America Point-Of-Care-Testing Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospectus
Executive Summary North America Point-Of-Care-Testing (POCT) Market :
North America Point-Of-Care Testing (POCT) market size was valued at USD 16.29 billion 2024 and is projected to reach USD 33.68 billion by 2032, with a CAGR of 9.5% during the forecast period of 2025 to 2032.
Market research analysis carried out in this North America Point-Of-Care-Testing (POCT) Market report imparts its own benefits and advantages that will support to grow your business whether it is small or large size. The report gives several insights that will help to take your business in the right direction. Market research analysis conducted in this North America Point-Of-Care-Testing (POCT) Market report is a powerful method that gives answers to many of your business challenges more quickly. Many professionals and businessmen rely on such syndicated market research report which acts as a go-to solution for them. North America Point-Of-Care-Testing (POCT) Market research report save hours of time as well as add credibility to the work done.
In this fast-paced industry, market research or secondary research provided in this North America Point-Of-Care-Testing (POCT) Market report is the best way to collect information quickly. The market research analysis of this report is carried out with the reliable knowledge of what the market expects, what already exists in the market, the competitive environment, and what steps to take to outshine the competition. Furthermore, market research report help to validate information gathered through primary sources. Such North America Point-Of-Care-Testing (POCT) Market research report guide professionals for changes and offer them ways to justify what third parties say so that they are not prejudiced.
Discover the latest trends, growth opportunities, and strategic insights in our comprehensive North America Point-Of-Care-Testing (POCT) Market report. Download Full Report: https://www.databridgemarketresearch.com/reports/north-america-point-care-testing-poct-market
North America Point-Of-Care-Testing (POCT) Market Overview
**Segments**
- By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Testing Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Others) - By Prescription (Prescription-Based Testing, Prescription-Free/OTC Testing) - By Distribution Channel (Direct Tenders, Retail Sales) - By End User (Hospitals, Home Healthcare, Clinics, Ambulatory Care Settings, Diagnostic Laboratories, Others)
The North America Point-Of-Care-Testing (POCT) market is segmented based on various factors such as product, prescription, distribution channel, and end-user. Blood glucose testing kits, cardiometabolic monitoring kits, and infectious disease testing kits are among the key products driving market growth. The rise in chronic diseases like diabetes and cardiovascular disorders has increased the demand for blood glucose testing kits and cardiometabolic monitoring kits. Infectious disease testing kits are crucial for timely diagnosis and treatment of diseases like COVID-19. Additionally, with the increasing trend of self-monitoring and self-care, prescription-free/OTC testing is gaining popularity, especially in retail sales channels and home healthcare settings.
**Market Players**
- Abbott - Roche Diagnostics - Siemens Healthineers - Danaher - BD - Quidel Corporation - BioMérieux SA - OraSure Technologies, Inc. - Instrumentation Laboratory - PTS Diagnostics - Nova Biomedical - Trividia Health, Inc. - Sysmex Corporation - EKF Diagnostics - AccuBioTech
The North America POCT market is highly competitive with the presence of key players like Abbott, Roche Diagnostics, and Siemens Healthineers dominating the market. These companies focus on product innovation, strategic partnerships, and mergers and acquisitions to maintain their market position. Abbott, for instance, has a strong portfolio of POCT products such as blood glucose monitoring systems and infectious disease testing kits. Roche Diagnostics is known for its advanced technologies in cardiometabolic monitoring kits, while Siemens Healthineers specializes in offering comprehensive POCT solutions for various healthcare settings. Other notable players like Danaher and BD also play a significant role in driving market growth through their diversified product offerings and strong distribution networks.
The North America Point-Of-Care-Testing (POCT) market is witnessing significant growth due to various factors such as technological advancements, increasing prevalence of chronic diseases, and the growing emphasis on early disease detection and personalized medicine. One emerging trend in the market is the integration of POCT devices with digital health platforms, allowing for remote monitoring and real-time data sharing between patients and healthcare providers. This trend is particularly impactful in home healthcare settings, where patients can conveniently monitor their health conditions and share relevant data with their healthcare professionals.
Another key factor driving market growth is the expanding applications of POCT beyond traditional clinical settings. POCT devices are increasingly being utilized in non-traditional settings such as schools, workplaces, and community health centers for rapid screening and early detection of infectious diseases. The convenience, speed, and accuracy of POCT devices make them ideal for such settings, where immediate results are crucial for timely decision-making and intervention.
In terms of product development, there is a growing focus on the miniaturization and portability of POCT devices, enabling point-of-care testing to be performed in resource-limited settings or remote locations. These portable devices offer healthcare providers flexibility in delivering patient care and expanding access to diagnostic services in underserved areas. Moreover, the integration of artificial intelligence and machine learning algorithms in POCT devices is enhancing diagnostic accuracy and enabling predictive analytics for better patient outcomes.
The market is also witnessing a shift towards personalized medicine, where POCT devices are used to tailor treatment plans based on individual patient characteristics and genetic profiles. By providing rapid and on-the-spot test results, POCT devices allow for real-time adjustments to treatment regimens, optimizing therapeutic efficacy and minimizing adverse effects. This personalized approach to healthcare not only improves patient outcomes but also reduces healthcare costs associated with trial-and-error treatments.
In conclusion, the North America POCT market is poised for continued growth and innovation driven by advancements in technology, the expansion of application areas, and the emphasis on personalized medicine. Market players are expected to focus on developing next-generation POCT devices with enhanced connectivity, accuracy, and convenience to meet the evolving needs of healthcare providers and patients. Additionally, collaborations between industry players, healthcare stakeholders, and regulatory bodies will be crucial in shaping the future landscape of POCT and accelerating its integration into mainstream healthcare practices.The North America Point-Of-Care-Testing (POCT) market is a dynamic and competitive industry driven by technological advancements and the increasing prevalence of chronic diseases. Market players such as Abbott, Roche Diagnostics, and Siemens Healthineers are at the forefront of innovation, focusing on product development and strategic partnerships to maintain their market position. These companies offer a wide range of POCT products, catering to different healthcare settings and end-users.
One of the key trends shaping the POCT market is the integration of POCT devices with digital health platforms. This integration enables remote monitoring and real-time data sharing, enhancing patient care and facilitating timely interventions. As home healthcare settings gain prominence, the demand for convenient and accessible POCT solutions is expected to rise, driving further market growth in this segment.
Additionally, the expanding applications of POCT beyond traditional clinical settings are contributing to market expansion. POCT devices are increasingly being used in schools, workplaces, and community health centers for rapid screening and early detection of diseases. The speed and accuracy of POCT devices make them valuable tools in settings where immediate results are essential for decision-making and intervention.
Furthermore, the development of miniaturized and portable POCT devices is opening up opportunities for testing in resource-limited or remote areas. These devices offer flexibility to healthcare providers and improve access to diagnostics in underserved regions. The incorporation of artificial intelligence and machine learning algorithms is enhancing diagnostic accuracy and enabling predictive analytics, further improving patient outcomes.
The shift towards personalized medicine is also influencing the POCT market, with devices being used to customize treatment plans based on individual patient characteristics. Real-time test results provided by POCT devices facilitate adjustments to treatment regimens, optimizing therapeutic effectiveness and reducing adverse effects. This personalized approach not only benefits patients but also helps in cost reduction associated with ineffective treatments.
In conclusion, the North America POCT market is set for continued growth fueled by technological advancements, expanding application areas, and the focus on personalized medicine. Market players will continue to innovate and collaborate to meet the evolving needs of healthcare providers and patients. The integration of POCT into mainstream healthcare practices will be crucial in improving patient care, driving efficiency, and reducing healthcare costs in the long run.
The North America Point-Of-Care-Testing (POCT) Market is highly fragmented, featuring intense competition among both global and regional players striving for market share. To explore how global trends are shaping the future of the top 10 companies in the keyword market.
Learn More Now: https://www.databridgemarketresearch.com/reports/north-america-point-care-testing-poct-market/companies
DBMR Nucleus: Powering Insights, Strategy & Growth
DBMR Nucleus is a dynamic, AI-powered business intelligence platform designed to revolutionize the way organizations access and interpret market data. Developed by Data Bridge Market Research, Nucleus integrates cutting-edge analytics with intuitive dashboards to deliver real-time insights across industries. From tracking market trends and competitive landscapes to uncovering growth opportunities, the platform enables strategic decision-making backed by data-driven evidence. Whether you're a startup or an enterprise, DBMR Nucleus equips you with the tools to stay ahead of the curve and fuel long-term success.
Regional Analysis/Insights
The North America Point-Of-Care-Testing (POCT) Market is analyzed and market size insights and trends are provided by country, component, products, end use and application as referenced above.
The countries covered in the North America Point-Of-Care-Testing (POCT) Market reportare U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominatesthe North America Point-Of-Care-Testing (POCT) Market because of the region's high prevalence North America Point-Of-Care-Testing (POCT) Market
Asia-Pacific is expectedto witness significant growth. Due to the focus of various established market players to expand their presence and the rising number of surgeries in this particular region.
Browse More Reports:
Global Coconut Water Market Global Medical Billing Software Market Global Public Safety Solution Market Global Gourmet Salt Market Middle East and Africa API Intermediates Market Asia-Pacific Loyalty Management Market Global Bone Substitutes Market Global Heat Transfer Film Market Global Aquafeed Premix Market Global Soy Protein Isolate Market Global Vaginitis Therapeutics Market Global Methyl Methacrylate (MMA) Film and Sheet Market North America API intermediates Market Global Remote Patient Monitoring and Care Market Global Minocycline Hydrochloride Market Global In Vivo Preclinical Brain Imaging Devices Market Europe and U.S. Cleaner and Degreaser Market Global Necrotizing Fasciitis Market Global Household Cooking Appliances Market India Non-Stick Cookware Market Global Catheter Stabilization Device/Catheter Securement Devices Market Global Antidepressants Market Global Electronics Access Control Systems Market Global Vapour Recovery Units Market Global Golf Trolley Market Global Trichiasis Treatment Market Global Baricitinib Market Middle East and Africa Microbial Air sampler Market Global Weight Management Diet Market Global Data Center Server Market Global Cell Culture Market Middle East and Africa Metal Injection Molding (MIM) Market Global Patient Engagement Solutions Market Global Rock Salt Market
About Data Bridge Market Research:
An absolute way to forecast what the future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Contact Us: Data Bridge Market Research US: +1 614 591 3140 UK: +44 845 154 9652 APAC : +653 1251 975 Email:- [email protected]
0 notes
Text
Global Point of Care Testing Market Is Set For Global Lead With Immense Development Trends By 2026
Global point of care testing market is expected to reach USD 41.7 billion by 2026, growing at a substantial CAGR of 8.4% in the forecast period 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.
Competitive Analysis: Global Point of Care Testing Market
Global point of care testing market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of point of care testing market for Global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Key Market Competitors:
Some of the major players operating in global point of care testing market are Abbott, F. Hoffmann-La Roche Ltd, Siemens AG, Beckman Coulter, Inc., BD , Johnson & Johnson Services, Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific Electronics, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics Inc., bioMérieux SA, Biomerica, Inc., Binx Health, Inc., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, Nova Biomedical and others
Download Sample PDF Copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=point-care-testing-poct-market
Market Drivers
Increasing geriatric population
Increase in infectious diseases (hepatitis, HIV infection, influenza, respiratory infections and others)
Technological advancements
Rapid economic development in the emerging economies
Market Restraints
High cost for point of care testing devices
Product recalls and reluctance from the industry towards changing the existing norms
Segmentation: Global Point of Care Testing Market
By Product Type
Blood Glucose Testing Kits
Cardiometabolic Monitoring Kits
Cardiac Markers
Blood gas/Electrolytes Testing Kits
HbA1c Testing Kits
Lipids Testing
Infectious Disease Testing Kits
Influenza Testing Kits
HIV Testing Kits
Hepatitis C Testing Kits
Sexually-Transmitted Diseases Testing Kits
Tropical Diseases Testing Kits
Healthcare-Associated Infections
Respiratory Infections Testing Kits
Others
Cholesterol Testing Kits
Prothrombin Time Testing Kits
Activated Clotting Time Testing Kit
Pregnancy and Fertility Tests Kits
Tumor/Cancer Markers
Urinalysis Testing Kits
Cholesterol Test Strips
Hematology Testing Kits
Drugs of Abuse Testing Kits
Fecal Occult Testing Kits
Rapid Coagulation Testing Kits
Others
By Prescription Mode
Prescription Based Testing
Over-the-counter (OTC) Testing
Distribution Channel
Direct Tenders
Retail
By End- User
Hospitals
Emergency Department Critical-Care Unit
General Ward
Others (intensive care unit, neo-natal)
Clinics
Physicians Clinic
Diagnostic Clinic
Home Healthcare
Ambulatory Care
Research Laboratory
By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Inquire Regarding This Report https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=point-care-testing-poct-market
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email: [email protected]
0 notes